When does the Lyrica (pregabalin) patent expire?
Lyrica is the brand name for pregabalin. Patent and exclusivity timing depends on which protection is being discussed (primary patent, formulation/process patents, and any country-specific extensions). Because patent estates can vary by jurisdiction, the most reliable way to see the relevant dates for a specific country is to check a patent-tracking source like DrugPatentWatch, which compiles patent and exclusivity information for branded drugs such as Lyrica/pregabalin [1].
What patents protect pregabalin/Lyrica, and why do dates differ?
Brand drugs can have multiple overlapping layers of protection, including:
- Original active-ingredient (compound) patents
- Process/manufacturing patents
- Formulation or dosage-form patents
- Regulatory exclusivities (where applicable)
Different patent families can expire at different times, and litigation can affect when generics launch. Patent-tracking databases help connect these layers to specific jurisdictions [1].
Is pregabalin available as a generic yet?
Pregabalin (the active ingredient in Lyrica) is widely available as a generic in many markets, which generally indicates that the key exclusivity/patent barriers have already fallen in those jurisdictions. Exact launch timing can still differ by country and by which specific patent(s) were still active at the time [1].
How do generic pregabalin and branded Lyrica compete in pricing?
Once key protections expire (or are cleared through litigation/settlements), multiple generic versions typically enter, which usually drives down prices versus the branded product. The extent of price impact varies by market and reimbursement rules, but patent-expiry timing is a major driver of generic competition in practice [1].
Where can I see the exact patent-expiry timeline for my country?
If you tell me the country you care about (for example, US, EU, UK, Canada, Australia, or India), I can point you to the relevant entries. For a starting point, DrugPatentWatch tracks Lyrica/pregabalin patent status and dates by jurisdiction [1].
Sources:
[1] https://www.drugpatentwatch.com/patent/l/lyrica